corporate compliance
program and which relates to clinical trials conducted at the hospital.
MedCath Corporation, headquartered in Charlotte, N.C., is a healthcare
provider focused on high acuity services with the diagnosis and treatment
of cardiovascular disease being a primary service offering. MedCath owns
interests in and operates eleven hospitals with a total of 667 licensed
beds, located in Arizona, Arkansas, California, Louisiana, New Mexico,
Ohio, South Dakota, and Texas. In addition, MedCath and its subsidiary
MedCath Partners manage the cardiovascular program at various hospitals and
provide services in diagnostic and therapeutic facilities in various
states.
'/>"/>SOURCE MedCath Corporation Copyright©2007 PR Newswire. All rights reserved | |
Page: 1 2 Related medicine technology :1.
Video: The Arizona Heart Institute Announces the Largest Worldwide Experience with Endoluminal Grafting to Treat Thoracic Aortic Aneurysms and Related Pathologies2.
Many Heart Attack Patients Dont Get Best Emergency Treatment3.
The Heart, Diabetes, And Weight Loss Centers of New York Introduce the New Science of Metabolic Diagnosis and Weight Management4.
American Heart Association Comment Saving Lives in Type 2 Diabetics: Could It Be as Easy as Lowering Blood Pressure?5.
Terumo Heart to Announce Results of European Clinical Trial of DuraHeart(TM) LVAS at European Association of Cardiothoracic Surgeons Meeting in September6.
WorldHeart Announces Further Milestone in Miniaturized Assist Pump Development7.
CellCyte Genetics Corp. Enters Collaborative Research Agreement With Cleveland Clinic Foundation to Qualify Stem Cell Delivery in Damaged Heart Tissue8.
Its Only Heartburn...or is it? Chronic Heartburn a Risk Factor for Precursor to Esophageal Cancer9.
Cleveland Clinic Study Shows the Diabetes Drug Pioglitazone Reduces Risk of Death, Heart Attack and Stroke, but Increases Risk of Heart Failure10.
Hypertension: Journal of the American Heart Association Rapid Access Reports: Hispanics Hypertension Better Controlled With Equal Access to Care11.
Terumo Heart Reports Summary of DuraHeart(TM) LVAS Clinical Trial Results